Claris Ventures is the first operator in Italy with the investment strategy focused on biotech projects ready to start clinical studies in which Claris Ventures will provide the resources to fund the eventual completion of preclinical studies and a first human study. Among the therapeutic areas of primary interest are oncology, rare diseases and other indications in which treatment options are severely limited.
Proof of Concept
Claris Ventures stands on the side of researchers to allow them to focus on the scientific aspects in which they excel, contributing instead to every element of project management, finance and strategic development that transforms the fruit of research into a biotech company.
Claris Ventures invests in Italian biotech companies but also in new biotechs born on the work of Italian researchers abroad, supporting the birth of these projects in our country.